Compare Raymond James Financial, Inc. (RJF) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Raymond James Financial, Inc. vs Twist Bioscience Corp — how do they compare? Raymond James Financial, Inc. trades at $167 (market cap $32.73B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Raymond James Financial, Inc. is far larger — about 5.5× Twist Bioscience Corp's market cap, and Raymond James Financial, Inc. pays a 1.29% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| RJF | TWST | |
|---|---|---|
Market Cap | $32.73B | $5.97B |
Sector | Financials | Health |
52-Week High | $176.43 | $102.88 |
52-Week Low | $140.89 | $24.16 |
Dividend Yield | 1.29% | — |
Enterprise Value | — | $5.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
